Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 10 | 2025 | 298 | 4.390 |
Why?
|
| Liver | 12 | 2025 | 1860 | 2.580 |
Why?
|
| Circadian Clocks | 5 | 2025 | 72 | 1.870 |
Why?
|
| Lipid Metabolism | 5 | 2025 | 386 | 1.200 |
Why?
|
| Gene Expression Regulation | 7 | 2025 | 2651 | 1.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 4 | 2023 | 23 | 1.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2025 | 323 | 0.980 |
Why?
|
| Quantitative Trait Loci | 1 | 2025 | 314 | 0.830 |
Why?
|
| Hepatocytes | 3 | 2023 | 245 | 0.820 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2023 | 30 | 0.790 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 1420 | 0.720 |
Why?
|
| Genetic Variation | 2 | 2025 | 1597 | 0.660 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 121 | 0.650 |
Why?
|
| Professional Misconduct | 1 | 2019 | 35 | 0.630 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 73 | 0.600 |
Why?
|
| PPAR alpha | 1 | 2018 | 54 | 0.580 |
Why?
|
| Lipogenesis | 4 | 2023 | 59 | 0.520 |
Why?
|
| Feeding Behavior | 2 | 2020 | 728 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3363 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1420 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4823 | 0.360 |
Why?
|
| Mice | 14 | 2025 | 18936 | 0.360 |
Why?
|
| Diet | 1 | 2018 | 1169 | 0.350 |
Why?
|
| Animals | 16 | 2025 | 36222 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2855 | 0.270 |
Why?
|
| Obesity | 1 | 2018 | 2440 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2025 | 3979 | 0.250 |
Why?
|
| Hymecromone | 1 | 2025 | 10 | 0.240 |
Why?
|
| Drug Repositioning | 1 | 2025 | 31 | 0.240 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2025 | 16 | 0.230 |
Why?
|
| Fungi | 1 | 2025 | 75 | 0.230 |
Why?
|
| Adipocytes | 3 | 2022 | 179 | 0.220 |
Why?
|
| Indoles | 1 | 2025 | 202 | 0.220 |
Why?
|
| Acetate-CoA Ligase | 1 | 2023 | 4 | 0.220 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 98 | 0.210 |
Why?
|
| Transcriptome | 3 | 2025 | 1135 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2025 | 396 | 0.180 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 829 | 0.180 |
Why?
|
| Peptides | 1 | 2025 | 863 | 0.180 |
Why?
|
| Thiazolidinediones | 1 | 2022 | 86 | 0.180 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2021 | 10 | 0.180 |
Why?
|
| Gene Expression | 2 | 2023 | 1608 | 0.170 |
Why?
|
| RNA, Small Untranslated | 1 | 2021 | 21 | 0.170 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 947 | 0.170 |
Why?
|
| Epigenomics | 1 | 2021 | 196 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2020 | 806 | 0.160 |
Why?
|
| Cell Communication | 1 | 2020 | 190 | 0.160 |
Why?
|
| Hippocampus | 1 | 2025 | 861 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2023 | 494 | 0.150 |
Why?
|
| Fatty Liver | 2 | 2018 | 215 | 0.150 |
Why?
|
| Genotype | 1 | 2025 | 2720 | 0.150 |
Why?
|
| Communication | 1 | 2023 | 542 | 0.150 |
Why?
|
| RNA | 1 | 2022 | 606 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2021 | 401 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 424 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2017 | 18 | 0.140 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 3 | 0.140 |
Why?
|
| Light | 1 | 2018 | 183 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 12 | 0.140 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2017 | 13 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 429 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 882 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 133373 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 77 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 700 | 0.130 |
Why?
|
| Genome | 1 | 2019 | 528 | 0.130 |
Why?
|
| Male | 6 | 2025 | 65592 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 259 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2019 | 509 | 0.120 |
Why?
|
| Interferon-alpha | 1 | 2017 | 246 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 1849 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2020 | 872 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 230 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 492 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 504 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 748 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 2145 | 0.100 |
Why?
|
| Actinin | 1 | 2012 | 7 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 52 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 351 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2012 | 244 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 945 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2022 | 89 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2012 | 378 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2025 | 384 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2524 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 478 | 0.070 |
Why?
|
| Female | 2 | 2025 | 71503 | 0.070 |
Why?
|
| Protein Binding | 3 | 2019 | 1852 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1757 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2022 | 432 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 139 | 0.060 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2025 | 28 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 109 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4760 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 134 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2023 | 77 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 302 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2853 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3794 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 428 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 128 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 281 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 22 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2019 | 54 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 314 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2017 | 8 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 822 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2019 | 363 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 66 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2017 | 119 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 108 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1395 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 213 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 573 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 225 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 500 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 546 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1559 | 0.030 |
Why?
|
| Motor Activity | 1 | 2018 | 528 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 3153 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 1185 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1433 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 815 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2025 | 4917 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 212 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 745 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3131 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 700 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 829 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 767 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1612 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 21500 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 28985 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31684 | 0.010 |
Why?
|